Cumberland Pharmaceuticals (CPIX) Other financing activities (2010 - 2022)
Cumberland Pharmaceuticals (CPIX) reported Other financing activities of -$370464.0 for Q1 2022, down 232.3% on a YoY basis from $280020.0 in Q1 2021, and up 41.44% sequentially from -$632646.0 in Q4 2021.
Cumberland Pharmaceuticals (CPIX) Other financing activities (2010 - 2022) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 12 years of Other financing activities data on file, last reported at -$370464.0 in Q1 2022.
- For the quarter ending Q1 2022, Other financing activities fell 232.3% year-over-year to -$370464.0; the trailing twelve-month figure through Mar 2022 stood at -$650484.0 (down 147.35% YoY), and the FY2019 full-year result was $52500.0, changed N/A from the prior year.
- Other financing activities climbed to -$370464.0 in Q1 2022, from -$632646.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $543006.0 in Q1 2020 to a low of -$806390.0 in Q4 2020.
- A 4-year average of -$24458.8 and a median of $102565.0 in 2020 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities surged 181.39% in 2021 and sank 232.3% in 2022, its largest moves.
- Tracing CPIX's Other financing activities over 4 years: stood at -$629077.0 in 2019, then dropped by 28.19% to -$806390.0 in 2020, then advanced by 21.55% to -$632646.0 in 2021, then surged by 41.44% to -$370464.0 in 2022.
- Business Quant data shows CPIX's Other financing activities at -$370464.0 in Q1 2022, -$632646.0 in Q4 2021, and $452536.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -370,464.00 |
| Mar 31, 2022 | -370,464.00 |
| Dec 31, 2021 | -632,646.00 |
| Dec 31, 2021 | -632,646.00 |
| Sep 30, 2021 | 452,536.00 |
| Sep 30, 2021 | 452,536.00 |
| Jun 30, 2021 | -99,910.00 |
| Jun 30, 2021 | -99,910.00 |
| Mar 31, 2021 | 280,020.00 |
| Mar 31, 2021 | 280,020.00 |
| Dec 31, 2020 | -806,390.00 |
| Dec 31, 2020 | -806,390.00 |
| Sep 30, 2020 | 160,819.00 |
| Sep 30, 2020 | 160,819.00 |
| Jun 30, 2020 | 102,565.00 |
| Jun 30, 2020 | 102,565.00 |
| Mar 31, 2020 | 543,006.00 |
| Mar 31, 2020 | 543,006.00 |
| Dec 31, 2019 | -629,077.00 |
| Dec 31, 2019 | -629,077.00 |